Health Care

AstraZeneca earnings fall amid patent protection losses

Anglo-Swedish drugmaker AstraZeneca says its net income and sales fell in the third quarter as it worked to make up for the loss of patent protection for major products such as Crestor and Seroquel XR.

Nissan's profit flat over inspection scandal, legal costs

Japanese automaker Nissan Motor Co. is seeing fiscal second-quarter profit slip 3 percent despite growing sales because of costs related to improper vehicle checks in Japan and a massive global air-bag recall in the U.S. Nissan, allied with Renault SA of France, reported Wednesday a July-September profit of 141.6 billion yen ($1.2 billion), down from 146.1 billion yen the same period last year.

Valeant beats Street 3Q forecasts

Valeant Pharmaceuticals International Inc. (VRX) on Tuesday reported third-quarter net income of $1.3 billion, after reporting a loss in the same period a year earlier.